Concepedia

Mikael Rehngren

MR

Statistics

Publications

3

Citations

445

H-Index

3

Active since

2005

Affiliations

AstraZeneca (Sweden)(Current)

Mikael Rehngren is an author at AstraZeneca (Sweden) specializing in equilibrium dialysis, fraction unbound drug, and high-throughput screening assays.

Publications per year

2005–2010

3

Publications

3

Measurement of Unbound Drug Exposure in Brain: Modeling of pH Partitioning Explains Diverging Results between the Brain Slice and Brain Homogenate Methods

Markus Fridén, Fredrik Bergström, Hong Wan et al. · Drug Metabolism and Disposition · 2010 · 183 citations

, , +17

High-Throughput Screening of Drug−Brain Tissue Binding and in Silico Prediction for Assessment of Central Nervous System Drug Delivery

Hong Wan, Mikael Rehngren, Fabrizio Giordanetto et al. · Journal of Medicinal Chemistry · 2007 · 144 citations

, , +15

High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry

Hong Wan, Mikael Rehngren · Journal of Chromatography A · 2005 · 118 citations

, , +16

1–3 of 3